SBI Securities Co., Ltd.
Broker-DealerPosition in BTAI — BioXcel Therapeutics, Inc.
CIK 1851815
TOKYO, M0
Position in BTAI
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$18
+$0 QoQ
Shares Held
13
-7.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#41
of 47 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BTAI Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026SBI Securities Co., Ltd. holds $3,605,672 across 52 Drug Manufacturers - Specialty & Generic names. BTAI ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HIMS |
Hims & Hers Health, Inc.
|
40,962 | $1,420,152 | |
| 2 | CGC |
Canopy Growth Corp
|
682,715 | $648,579 | |
| 3 | HLN |
Haleon plc
|
37,625 | $351,041 | |
| 4 | ZTS |
Zoetis Inc.
|
3,686 | $264,875 | |
| 5 | VTRS |
Viatris Inc
|
16,323 | $259,209 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
410 | $222,150 | |
| 7 | TLRY |
Tilray Brands, Inc.
|
25,466 | $114,342 | |
| 8 | HROW |
Harrow, Inc.
|
1,271 | $53,979 |
All Filings in BTAI
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $18 | 13 | Shares | Defined | 2026-07-23 | |
| 2026-03-31 | $18 | 14 | Shares | Defined | 2026-04-28 | |
| 2025-12-31 | $270 | 169 | Shares | Defined | 2026-02-03 | |
| 2025-09-30 | $432 | 169 | Shares | Defined | 2025-11-05 | |
| 2025-06-30 | $1,590 | 879 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $1,727 | 851 | Shares | Defined | 2025-05-02 | |
| 2024-12-31 | $4,750 | 12,701 | Shares | Defined | 2025-02-06 | |
| No filing history on record for this holder in this stock. | ||||||